The Financial Times Adviser reported that two healthcare focused investment trusts, Medicx and Primary Healthcare Properties (PHP), are to merge, creating a fund with a market cap of more than £1 billion (US$1.3 billion).
The all-share merger, which values MedicX shares at 88.7 pence (US$1.16), or £393 million (US$ million), will create a firm that has 479 properties, many of which are leased to the National Health Service (NHS) and used for X-rays and blood tests.
Harry Hyman, PHP CEO, will lead the new larger company. He said, “The two businesses are complementary in terms of the properties they own, and from our point of view, if we were to try to buy £800m of properties, which come as part of this merger, it would take a long time.”
The chairman of the Medicx is to become deputy chairman of the combined business.
Full Content: Financial Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Croatian Supermarket Chain Tommy Cleared to Acquire Brodokomerc Nova
Oct 13, 2024 by
CPI
X and Unilever Settle Antitrust Dispute, Continuing Partnership
Oct 13, 2024 by
CPI
Federal Judge Allows Antitrust Claims Against GoDaddy to Proceed
Oct 13, 2024 by
CPI
Court Ruling Opens Door for Microsoft to Sell Xbox Games on Android Without Google’s Cut
Oct 13, 2024 by
CPI
Realtors Appeal to Supreme Court Over DOJ’s Investigation into Antitrust Violations
Oct 13, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Refusal to Deal
Sep 27, 2024 by
CPI
Antitrust’s Refusal-to-Deal Doctrine: The Emperor Has No Clothes
Sep 27, 2024 by
Erik Hovenkamp
Why All Antitrust Claims are Refusal to Deal Claims and What that Means for Policy
Sep 27, 2024 by
Ramsi Woodcock
The Aspen Misadventure
Sep 27, 2024 by
Roger Blair & Holly P. Stidham
Refusal to Deal in Antitrust Law: Evolving Jurisprudence and Business Justifications in the Align Technology Case
Sep 27, 2024 by
Timothy Hsieh